7.00
前日終値:
$7.075
開ける:
$6.98
24時間の取引高:
2,931
Relative Volume:
0.17
時価総額:
$19.45M
収益:
$22.03M
当期純損益:
$-19.91M
株価収益率:
-0.3781
EPS:
-18.5137
ネットキャッシュフロー:
$-16.84M
1週間 パフォーマンス:
-1.27%
1か月 パフォーマンス:
+2.04%
6か月 パフォーマンス:
+5.11%
1年 パフォーマンス:
-58.03%
Lifeward Ltd Stock (LFWD) Company Profile
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
LFWD
Lifeward Ltd
|
7.00 | 19.66M | 22.03M | -19.91M | -16.84M | -18.51 |
|
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
|
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-10 | 開始されました | Laidlaw | Buy |
| 2017-04-03 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2016-12-16 | 開始されました | Oppenheimer | Outperform |
| 2016-07-15 | 開始されました | Piper Jaffray | Overweight |
| 2015-05-22 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | 繰り返されました | Barclays | Equal Weight |
| 2014-10-07 | 開始されました | Barclays | Equal Weight |
すべてを表示
Lifeward Ltd (LFWD) 最新ニュース
Study of Lifeward exoskeleton found zero fractures in 97 Germany users - Stock Titan
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton - Yahoo Finance Singapore
Working capital per share of Lifeward Ltd. – MUN:2RW - TradingView
Lifeward (LFWD) price target increased by 344.44% to 20.40 - MSN
7.26M Lifeward shares registered for resale by selling holders (NASDAQ: LFWD) - Stock Titan
Lifeward stock plummets on pricing of $2.6M public offering - MSN
Jeannine Lynch to Exit Lifeward as VP of Strategy and Market Access - TradingView
Lifeward (NASDAQ: LFWD) to end VP Strategy role May 3 - Stock Titan
Moshe H Rozenbaum Net Worth (2026) - GuruFocus
William Mark Sigsbee Net Worth (2026) - GuruFocus
Lifeward (LFWD) director receives 11,485 RSUs vesting over four quarters - Stock Titan
Lifeward Ltd. (LFWD) director submits Form 3 with no insider trades - Stock Titan
Lifeward (LFWD) awards 11,485 RSUs to company director - Stock Titan
Lifeward (LFWD) director Moshe H Rozenbaum files initial Form 3 - Stock Titan
Returns Recap: Can Lifeward Ltd be recession proofPortfolio Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
Recap Report: Is Lifeward Ltd a turnaround storyWeekly Trade Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Aug PreEarnings: Is Lifeward Ltd a good stock for dollar cost averaging2026 Reactions & Reliable Volume Spike Alerts - baoquankhu1.vn
Aug Setups: Why is Lifeward Ltd stock going upMarket Trend Report & High Accuracy Trade Alerts - baoquankhu1.vn
Lifeward scoops US$20M after completing Oratech Pharma takeover - Mugglehead Investment Magazine
Sell Signal: Does Lifeward Ltd offer margin of safety2026 Risk Factors & Technical Buy Zone Confirmation - baoquankhu1.vn
Big Picture: Will Lifeward Ltd benefit from government policyForecast Cut & Advanced Technical Signal Analysis - baoquankhu1.vn
S P Trends: Is Lifeward Ltd stock heavily shorted2026 Update & Safe Capital Investment Plans - baoquankhu1.vn
LFWD Earnings History & Surprises | EPS & Revenue Results | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
Oramed Completes Oratech Sale and Strategic Lifeward Financing - The Globe and Mail
Lifeward Restores Nasdaq Compliance With Audit Committee Changes - The Globe and Mail
Lifeward Ltd. 8-K SEC Filing March 2026: Company Information, NASDAQ Listing, and Entity Details - Minichart
Oramed (ORMP) completes Oratech sale and buys $9M Lifeward notes - Stock Titan
Lifeward regains Nasdaq compliance after audit committee appointments By Investing.com - Investing.com South Africa
Lifeward regains Nasdaq compliance after audit committee appointments - investing.com
Lifeward regains Nasdaq audit committee compliance after new appointments - TradingView
Lifeward (NASDAQ: LFWD) regains Nasdaq audit committee compliance after board change - Stock Titan
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Dow Update: Will Lifeward Ltd outperform small cap indexesMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Lifeward shares fall after Q4 results miss expectations - MSN
Lifeward (NASDAQ: LFWD) grants CFO options on 39,934 shares - stocktitan.net
Lifeward (LFWD) CEO awarded 172,698 options at $6.53 strike - Stock Titan
Director at Lifeward (LFWD) granted 7,657 RSUs vesting quarterly - stocktitan.net
Lifeward (LFWD) director receives 7,657 RSU grant under 2025 plan - stocktitan.net
Director Miriam Kidron receives 7,657-share RSU grant at Lifeward (NASDAQ: LFWD) - Stock Titan
Lifeward (LFWD) director Reznick Yehuda files initial insider Form 3 - Stock Titan
Lifeward (LFWD) director Nadav Kidron submits initial Form 3 ownership - stocktitan.net
Lifeward (LFWD) director Miriam Kidron submits initial Form 3 insider report - stocktitan.net
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan
Lifeward Completes Oratech Acquisition and Secures Private Financing - The Globe and Mail
Lifeward (LFWD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga France
Aug Spikes: Is Lifeward Ltd in a long term uptrend2026 Levels & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Lifeward closes Oramed partnership, secures $10 million funding By Investing.com - Investing.com Australia
Lifeward Ltd. 8-K Filing: Share Purchase Agreement Assignment to Oratech Ltd. and Entity Information (March 2026) - Minichart
Lifeward Closes Oramed Partnership, Acquires Oratech Pharma - Moomoo
Lifeward closes Oramed partnership, secures $10 million funding - Investing.com
Lifeward Ltd (LFWD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):